Publications

by | August 8, 2012 | Uncategorized

European Medicines Agency consultation on further GVP modules

The European Medicines Agency (EMA) has released the latest two modules on good pharmacovigilance practice (GVP) for public consultation as part of a number of pharmacovigilance activities in support of the new legislation, effective from July 2012.

The modules cover the following major processes in the safety monitoring of medicines:

– Module IV: Pharmacovigilance audits; and
– Module XV: Safety communication.

The Agency is seeking comments on the practical implementation of the legislation as outlined in these modules. The underlying legal requirements cannot be altered through this consultation process.

Please note that the deadline for comments for these draft guidelines is 21 September 2012.

Introduced by Peter Arlett, Head of Sector on Pharmacovigilance and Risk Management, DG SANCO website.

—-
For further information

– European Medicines Agency website – Pharmacovigilance

EPHA related articles
– [->art5000]
– [->art5115]
– [->art5197]

Get the EPHA Newsletter

The best of our activities, right in your inbox!